ArticleJournal of breast cancer2011

Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer.

Kyeongmee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.